DV
Dividend Vision

HAE — Haemonetics Corp.

Haemonetics Corp. (HAE)

Its deepest 1-year drawdown was 40.1%.

HAE is a single equity stock in the healthcare sector that trades as a public company rather than a diversified ETF fund. The security does not have a defined dividend distribution rate or yield profile currently. This holding appeals primarily to investors seeking direct equity exposure to a specific healthcare company rather than those focused on consistent dividend income or broad portfolio diversification.

HAE key facts

Asset type
Stock
Asset class
Equity
Inception date
05/10/1991
Distribution frequency
None
Last close
$90.80
Market cap
$4,131,132,416
Average volume
533270.0
Beta
0.518
Payout ratio
0.0
P/E ratio
43.6539
Forward P/E
15.1976
EPS
$2.08